Abstract
Recently we demonstrated clinically significant levels of a previously unrecognized metabolite of the anticancer drug 5-fluorouracil (FUra) in bile of cancer patients. In the present study, reanalysis of bile from these patients demonstrated the presence of not one but two previously unrecognized metabolites. The major unrecognized metabolite was purified by reversed-phase HPLC, after which its molecular weight was determined by fast-atom-bombardment mass spectrometry to be 497. The similarity in HPLC retention times and molecular weights of this FUra derivative and the bile acids N-cholylglycine (Mr 465) and N-cholyltaurine (Mr 515), along with the structural similarity of the FUra catabolite 2-fluoro-beta-alanine and the amino acids glycine and taurine, led to the hypothesis that this metabolite could be a conjugate of 2-fluoro-beta-alanine and cholic acid. This hypothesis was tested and confirmed by hydrolyzing the purified metabolite by cholylglycine hydrolase after which: 2-fluoro-beta-alanine was demonstrated by using a sensitive HPLC technique capable of resolving all of the known putative FUra metabolites, and unconjugated cholic acid was identified by both GC and GC-MS. Additionally, chemically synthesized N-cholyl-2-fluoro-beta-alanine was shown to cochromatograph on HPLC and TLC with the purified biliary metabolite. In summary, this study demonstrates a unique, so far as we know, pathway of drug metabolism in man in which an amino acid drug metabolite is conjugated with cholic acid and eliminated into the bile. Furthermore, the finding that 2-fluoro-beta-alanine is conjugated to bile acids may provide some insight into the mechanism of cholestasis that is frequently observed after administration of fluoropyrimidine by hepatic arterial infusion.
Full text
PDF




Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Barnes S., Berkowitz G., Hirschowitz B. I., Wirtschafter D., Cassady G. Postnatal physiologic hypercholemia in both premature and full-term infants. J Clin Invest. 1981 Sep;68(3):775–782. doi: 10.1172/JCI110314. [DOI] [PMC free article] [PubMed] [Google Scholar]
- EKDAHL P. H., BENNIKE T. On the conjugation and formation of bile acids in the human liver. V. On the conjugation of cholic acid - 2414C in homogenates of human liver specimens stored in deep-freeze unit; bile acids and steroids 65. Acta Chir Scand. 1958;115(3):203–207. [PubMed] [Google Scholar]
- Garbutt J. T., Lack L., Tyor M. P. Physiological basis of alterations in the relative conjugation of bile acids with glycine and taurine. Am J Clin Nutr. 1971 Feb;24(2):218–228. doi: 10.1093/ajcn/24.2.218. [DOI] [PubMed] [Google Scholar]
- Heggie G. D., Sommadossi J. P., Cross D. S., Huster W. J., Diasio R. B. Clinical pharmacokinetics of 5-fluorouracil and its metabolites in plasma, urine, and bile. Cancer Res. 1987 Apr 15;47(8):2203–2206. [PubMed] [Google Scholar]
- Heidelberger C., Danenberg P. V., Moran R. G. Fluorinated pyrimidines and their nucleosides. Adv Enzymol Relat Areas Mol Biol. 1983;54:58–119. [PubMed] [Google Scholar]
- Heidelberger C. Fluorinated pyrimidines. Prog Nucleic Acid Res Mol Biol. 1965;4:1–50. doi: 10.1016/s0079-6603(08)60783-7. [DOI] [PubMed] [Google Scholar]
- Hohn D., Melnick J., Stagg R., Altman D., Friedman M., Ignoffo R., Ferrell L., Lewis B. Biliary sclerosis in patients receiving hepatic arterial infusions of floxuridine. J Clin Oncol. 1985 Jan;3(1):98–102. doi: 10.1200/JCO.1985.3.1.98. [DOI] [PubMed] [Google Scholar]
- Huijghebaert S. M., Hofmann A. F. Pancreatic carboxypeptidase hydrolysis of bile acid-amino conjugates: selective resistance of glycine and taurine amidates. Gastroenterology. 1986 Feb;90(2):306–315. doi: 10.1016/0016-5085(86)90925-x. [DOI] [PubMed] [Google Scholar]
- Kemeny M. M., Goldberg D. A., Browning S., Metter G. E., Miner P. J., Terz J. J. Experience with continuous regional chemotherapy and hepatic resection as treatment of hepatic metastases from colorectal primaries. A prospective randomized study. Cancer. 1985 Mar 15;55(6):1265–1270. doi: 10.1002/1097-0142(19850315)55:6<1265::aid-cncr2820550619>3.0.co;2-r. [DOI] [PubMed] [Google Scholar]
- Lafon P. C., Reed K., Rosenthal D. Acute cholecystitis associated with hepatic arterial infusion of floxuridine. Am J Surg. 1985 Dec;150(6):687–689. doi: 10.1016/0002-9610(85)90409-x. [DOI] [PubMed] [Google Scholar]
- Nair P. P., Gordon M., Reback J. The enzymatic cleavage of the carbon-nitrogen bond in 3-alpha, 7-alpha, 12-alpha-trihydroxy-5-beta-cholan-24-oylglycine. J Biol Chem. 1967 Jan 10;242(1):7–11. [PubMed] [Google Scholar]
- Sommadossi J. P., Cross D. S., Gewirtz D. A., Goldman I. D., Cano J. P., Diasio R. B. Evidence from rat hepatocytes of an unrecognized pathway of 5-fluorouracil metabolism with the formation of a glucuronide derivative. Cancer Res. 1985 Jun;45(6):2450–2455. [PubMed] [Google Scholar]
- Sommadossi J. P., Gewirtz D. A., Diasio R. B., Aubert C., Cano J. P., Goldman I. D. Rapid catabolism of 5-fluorouracil in freshly isolated rat hepatocytes as analyzed by high performance liquid chromatography. J Biol Chem. 1982 Jul 25;257(14):8171–8176. [PubMed] [Google Scholar]
- Tserng K. Y., Hachey D. L., Klein P. D. An improved procedure for the synthesis of glycine and taurine conjugates of bile acids. J Lipid Res. 1977 May;18(3):404–407. [PubMed] [Google Scholar]
- Vessey D. A. The biochemical basis for the conjugation of bile acids with either glycine or taurine. Biochem J. 1978 Aug 15;174(2):621–626. doi: 10.1042/bj1740621. [DOI] [PMC free article] [PubMed] [Google Scholar]
